- Home
- RPD vs RXST Comparison
RPD vs RXST Comparison
Compare RPD & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPD
- RXST
- Stock Information
- Founded
- RPD 2000
- RXST 1997
- Country
- RPD United States
- RXST United States
- Employees
- RPD N/A
- RXST N/A
- Industry
- RPD Computer Software: Prepackaged Software
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- RPD Technology
- RXST Health Care
- Exchange
- RPD Nasdaq
- RXST Nasdaq
- Market Cap
- RPD 2.4B
- RXST 2.0B
- IPO Year
- RPD 2015
- RXST 2021
- Fundamental
- Price
- RPD $38.84
- RXST $30.39
- Analyst Decision
- RPD Buy
- RXST Strong Buy
- Analyst Count
- RPD 18
- RXST 8
- Target Price
- RPD $44.71
- RXST $58.13
- AVG Volume (30 Days)
- RPD 671.1K
- RXST 771.0K
- Earning Date
- RPD 02-12-2025
- RXST 02-26-2025
- Dividend Yield
- RPD N/A
- RXST N/A
- EPS Growth
- RPD N/A
- RXST N/A
- EPS
- RPD 0.66
- RXST N/A
- Revenue
- RPD $833,014,000.00
- RXST $128,293,000.00
- Revenue This Year
- RPD $9.10
- RXST $60.30
- Revenue Next Year
- RPD $5.35
- RXST $33.85
- P/E Ratio
- RPD $59.12
- RXST N/A
- Revenue Growth
- RPD 10.05
- RXST 67.52
- 52 Week Low
- RPD $32.95
- RXST $26.29
- 52 Week High
- RPD $61.88
- RXST $66.54
- Technical
- Relative Strength Index (RSI)
- RPD 42.30
- RXST 30.12
- Support Level
- RPD $37.57
- RXST $30.09
- Resistance Level
- RPD $40.42
- RXST $31.92
- Average True Range (ATR)
- RPD 1.20
- RXST 1.86
- MACD
- RPD 0.00
- RXST -0.06
- Stochastic Oscillator
- RPD 33.33
- RXST 37.82
About RPD Rapid7 Inc.
Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The Company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.